Financial Statements

Aptose Biosciences Inc. (APTO)


+0.05 (+0.80%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) -423-357-302-276-
Net Income -42-65-55-26-29
Stock Dividends -----247
Dividend Paid -----
Retained Earnings -464-423-357-302-276

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 1120-
Annual Depreciation 1-0-011
Capital Expenditure 0-0-0-0-0
Net PPE 21120

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -----
New Purchases --17--35-
Intangible and Goodwill -----

Aptose Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aptose Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.